Floatz logo

FLUOXETINE

Anxiety Disorder

Hannover Medical SchoolSmall moleculePhase 4 / ApprovedActive
BBB
74/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
95/ 100

Competitive context

18 Active assets in the Anxiety Disorder cohort.

Asset / SponsorPhaseRating
Risperdal
Tianjin Medical University General Hospital
Phase 4BBB
Sertraline
Holland Bloorview Kids Rehabilitation Hospital
Phase 4BBB
Olanzapine
Tianjin Medical University General Hospital
Phase 4BBB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Theresa Jacob, PhD, MPH
Phase 4BBB
Cipralex
Wake Forest University Health Sciences
Phase 4BB

View all 50 →

Same molecule, other indications

FLUOXETINE is also rated in:

depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
mood disorderDormant
BBB
Indicative ·
73 / 100
View asset →
dysthymic disorderDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →